BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/29/2024 8:12:37 AM | Browse: 19 | Download: 0
Category |
Cell Biology |
Manuscript Type |
Basic Study |
Article Title |
Preliminary study on the preparation of lyophilized acellular nerve scaffold complexes from rabbit sciatic nerves with human umbilical cord mesenchymal stem cells
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Chuang Qian, Shang-Yu Guo, Zheng Xu, Zhi-Qiang Zhang, Hao-Dong Li, Hao Li and Xiong-Sheng Chen |
Funding Agency and Grant Number |
|
Corresponding Author |
Hao Li, PhD, Department of Neurosurgery, Children’s Hospital of Fudan University & National Children’s Medical Center, No. 399 Wanyuan Road, Minghang District, Shanghai 201102, China. lihao7272@163.com |
Key Words |
Human umbilical cord mesenchymal stem cells; Peripheral nerve injury; Schwann cells; Acellular nerve scaffolds |
Core Tip |
The treatment of severe peripheral nerve injuries remains a clinical challenge, particularly in children. Autologous nerve grafts are the standard treatment for these severe neurologic deficits and the scarce number of autologous nerves and the loss of neurosensory function in the donor area are major obstacles, particularly in infants and young children. Allogeneic or xenografts are even more limited by immune rejection. Therefore, there is an urgent need for a peripheral nerve substitute that can bridge the two severed ends of the nerve, guide its axonal growth to avoid the formation of neuroma, and promote and guide the functional regeneration of the peripheral nerve. For patients with neonatal brachial plexus injury, human umbilical cord mesenchymal stem cells (hUC-MSCs) are an effective tool. In this study, we proposed to culture hUC-MSCs as seed cells on suitable decellularized scaffolds. |
Citation |
Qian C, Guo SY, Xu Z, Zhang ZQ, Li HD, Li H, Chen XS. Preliminary study on the preparation of lyophilized acellular nerve scaffold complexes from rabbit sciatic nerves with human umbilical cord mesenchymal stem cells. World J Stem Cells 2024; In press |
|
Received |
|
2024-08-20 08:16 |
|
Peer-Review Started |
|
2024-08-20 08:16 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-06 10:16 |
|
Revised |
|
2024-10-09 13:07 |
|
Second Decision |
|
2024-11-05 02:42 |
|
Accepted by Journal Editor-in-Chief |
|
2024-11-06 06:09 |
|
Accepted by Executive Editor-in-Chief |
|
2024-11-29 08:12 |
|
Articles in Press |
|
2024-11-29 08:12 |
|
Publication Fee Transferred |
|
2024-12-01 12:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345